4 results on '"Shafie, Asrul Akmal"'
Search Results
2. Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia.
- Author
-
Dzulkipli, Mohd Redhuan, Shafie, Asrul Akmal, Maon, Siti Noorsuriani, Ramli, Azuana, Yahaya, Abdul Haniff Mohammad, Ho, See Wan, Muhsin, Nor Ilham Ainaa, and Ahmat, Azmi Nor Mohd Farez
- Abstract
Early access to innovative oncology medicine is crucial to provide better treatment alternatives to patients with cancer. However, innovative oncology medicines often come at higher prices, thus limiting the government's ability for its universal coverage. Hence an alternative paying mechanism is needed. This study is intended to determine the willingness to pay (WTP) for innovative oncology medicines among Malaysians. A cross-sectional contingent valuation study on 571 Malaysians was conducted to elicit respondents' WTP value via bidding game approach. A double-bounded dichotomous choice was used in 3 hypothetical scenarios: innovative diabetes medicine, innovative oncology medicine one-off (IOMO), and innovative oncology medicine insurance. Univariate logistic regression was used to determine the factors affecting respondent's WTP, whereas the mean WTP value and the factors affecting amount to WTP was determined using a parametric 2-part model. This study received 95% response rate. The mean age of the respondents is 48 years (SD 17) with majority of the respondents female (60.3%) and from ethnic Malay (62%). About 343 (64.7%) of the respondents expressed WTP for IOMO. Those in higher income bracket were willing to pay more for the access of IOMO than the overall WTP mean value (P =.046, coefficient 351.57). More than half of Malaysian are willing to pay for IOMO at mean value of Malaysian Ringgit 279.10 (US dollar 66.77). Collaborative funding mechanisms and appropriate financial screening among the stakeholders could be introduced as methods to expedite the access of innovative oncology medicine among patients with cancer in Malaysia. • The high cost of innovative oncology medicine had put barrier to the wider access of the medicines to patients with cancer, especially in the public hospitals. • This article provides an insight of the factors that affect willingness to pay and amount to willingness to pay for the expedited access of innovative oncology medicine among patients with cancer in Malaysia. • Dynamic funding mechanism is needed to cover the cost of innovative oncology medicine thus increase the access to the advanced cancer treatment among patients with cancer in Malaysia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia.
- Author
-
Shiroiwa, Takeru, Murata, Tatsunori, Ahn, Jeonghoon, Li, Xue, Nakamura, Ryota, Teerawattananon, Yot, Kun, Zhao, Shafie, Asrul Akmal, Valverde, Haidee, Lam, Hilton, Ng, Kwong, Nadjib, Mardiati, Pwu, Raoh-Fang, Nugraha, Ryan Rachmad, Chen, Yong-Chen, and Fukuda, Takashi
- Abstract
Almost all preference-based measures (PBMs) have been developed in Western countries, with none having been formulated in Asian countries. In this study, we construct a new generic PBM based on concept elicitation using interview surveys in East and Southeast Asian countries and qualitative analysis. This cross-sectional study included 225 adults recruited from 9 East and Southeast Asian countries or regions (Indonesia, Japan, Korea, mainland China, Malaysia, the Philippines, Singapore, Taiwan, and Thailand). Trained interviewers conducted semistructured interviews with 25 participants from the general population of each country/region. Qualitative data were analyzed using a content analysis approach. The selection of items was determined based on interview surveys and team member discussions. The description of items was considered based on a detailed qualitative analysis of the interview survey. A new region-specific PBM—the Asia PBM 7 dimensions instrument—was designed. It reflects East and Southeast Asian values and comprises 7 items: pain, mental health, energy, mobility, work/school, interpersonal interactions, and burden to others. The new region-specific instrument is one of the first PBMs developed in the context of non-Western countries. The Asia PBM 7 dimensions contains 7 items that address the core concepts of health-related quality of life that are deemed important based on East and Southeast Asian health concepts. • Almost all preference-based measures (PBMs) were developed in Western countries. No major PBM has been developed in non-Western countries, including East and Southeast Asian countries. A new PBM, "Asia PBM 7 dimensions" (AP-7D), was designed by concept elicitation and item selection using interview surveys. The survey included a sample of 225 East and Southeast Asian people and qualitative analysis. • The AP-7D includes the following 7 items: pain, mental health, energy, mobility, work or school, interpersonal interactions, and burden to others, which are the most bothersome symptoms and the most important health-related impacts revealed by our interview surveys. • The scores measured using the AP-7D based on Asian people's concepts may reflect the truer preference of East and Southeast Asians. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia.
- Author
-
KC, Sarin, Faradiba, Dian, Sittimart, Manit, Isaranuwatchai, Wanrudee, Ananthakrishnan, Aparna, Rachatan, Chayapat, Dabak, Saudamini, Shafie, Asrul Akmal, Guerrero, Anna Melissa, Suwantika, Auliya, Kang, Gagandeep, Ahn, Jeonghoon, Hsu, Li Yang, Mayxay, Mayfong, Howard, Natasha, Wattanasri, Parinda, Nakamura, Ryota, George, Tarun K., and Teerawattananon, Yot
- Abstract
There are ongoing calls to harmonise and increase the use of COVID-19 vaccination certificates (CVCs) in Asia. Identifying groups in Asian societies who oppose CVCs and understanding their reasons can help formulate an effective CVCs policy in the region. However, no formal studies have explored this issue in Asia. The COVID-19 Vaccination Policy Research and Decision-Support Initiative in Asia (CORESIA) was established to address policy questions related to CVCs. An online cross-sectional survey was conducted from June to October 2021 in nine Asian countries. Multivariable logistical regression analyses were performed to identify potential opposers of CVCs. Six groups were identified as potential opposers of CVCs: (i) unvaccinated (Odd Ratio (OR): 2.01, 95% Confidence Interval (CI): 1.65-2.46); vaccine hesitant and those without access to COVID-19 vaccines; (ii) those not wanting existing NPIs to continue (OR: 2.97, 95% CI: 2.51-3.53); (iii) those with low level of trust in governments (OR: 1.25, 95% CI: 1.02-2.52); (iv) those without travel plans (OR: 1.58, 95% CI: 1.31-1.90); (v) those expecting no financial gains from CVCs (OR: 2.35, 95% CI: 1.98-2.78); and (vi) those disagreeing to use CVCs for employment, education, events, hospitality, and domestic travel. Addressing recurring public health bottlenecks such as vaccine hesitancy and equitable access, adherence to policies, public trust, and changing the narrative from 'societal-benefit' to 'personal-benefit' may be necessary and may help increase wider adoption of CVCs in Asia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.